News

CEQ508 is currently in a Phase 1b/2a clinical development program and is intended for the treatment of Familial Adenomatous Polyposis. CEQ508 comprises attenuated bacteria that are engineered to

NorLevo is an oral emergency contraceptive, which is taken within 72 hours after unprotected sexual intercourse or contraceptive failure to prevent unwanted pregnancy. Sosei has taken over the

Tranzyme Pharma’s Ulimorelin is indicated for the management of postoperative ileus (POI) in hospital and acute care settings. The companies are expecting to enroll about 300 bowel surgery

Covance Genomics Laboratory and Ingenuity will work together to develop new and novel approaches, using Ingenuity’s IPA software, to obtain more actionable insights from NGS data and to

Strive was designed to evaluate people with a mutation in the CF gene known as G551D. In the study, profound improvements in lung function (forced expiratory volume in

The Phase 3 trial was supported by the results from a cooperative group-sponsored Phase 2 clinical trial evaluating Nexavar in combination with capecitabine in patients with advanced breast

The agreement includes process development, scale-up and manufacturing for pre-clinical studies. OctoPlus evaluated the feasibility of a controlled release formulation that combines a proprietary eye care ingredient of

The trial, which began last month and is scheduled to finish in June 2011, aims to determine whether Antabuse can deplete the pool of residual virus that regular

In the study, consisting of 243 postmenopausal women, nitroglycerin cream demonstrated a capability to increase bone density by about 7% when applied daily to the upper arms for